2. Mahajan S, Bhagat H. Cerebral oedema: Pathophysiological mechanisms and experimental therapies. J Neuroanaesthesiol Crit Care. 2016; 3:22-28
4. Nehring SM, Tadi P, Tenny S. Cerebral Edema. [Updated 2021 Sep 29]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.
5. Cook AM, Jones GM, Hawryluk GWJ, Mailloux P, McLaughlin D, Papangelou A, Samuel S, Tokumaru S, Venkatasubramanian C, Zacko C, Zimmermann LL, Hirsch K, Shutter L. Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients. Neurocritical Care Society. 2020; 32:647-666
6. Koenig MA. Cerebral Edema and Elevated Intracranial Pressure. Continuum. 2018; 24:1588-1602
13. University Health System. Neurocritical Care Protocol for Hypertonic Saline Bolus and Continuous Infusion. 2018. https://www.universityhealthsystem.com/~/media/files/clinical-pathways/hypertonic-saline-2018.pdf?la=en
14. NHS. Guideline to make up hypertonic saline (3% NaCl). 2021. https://www.sort.nhs.uk/Media/Guidelines/Hypertonicsaline3sodiumchlorideguideline.pdf
15. Tenny S, Patel R, Thorell W. Mannitol. [Updated 2022 Feb 21]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.
21. Glaser N. Diabetic ketoacidosis in children: Cerebral injury (cerebral edema). Uptodate. 2021.
22. Palma L, Bruni G, Fiaschi AI, Mariottini A. Passage of mannitol into the brain around gliomas: a potential cause of rebound phenomenon. A study on 21 patients. J Neurosurg Sci 2006; 50:63.
23. Diringer MN. The Evolution of the Clinical Use of Osmotic Therapy in the Treatment of Cerebral Edema. In: Brain Edema XVI: Translate Basic Science into Clinical Practice, Applegate RL, Chen G, Feng H, Zhang JH (Eds), Springer International Publishing, 2016. p.3.